BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li LY, Yang JF, Rong F, Luo ZP, Hu S, Fang H, Wu Y, Yao R, Kong WH, Feng XW, Chen BJ, Li J, Xu T. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway. Acta Pharmacol Sin 2021;42:1676-89. [PMID: 33514855 DOI: 10.1038/s41401-020-00575-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohapatra P, Chandrasekaran N. Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: A review. Biomed Pharmacother 2022;155:113713. [PMID: 36126453 DOI: 10.1016/j.biopha.2022.113713] [Reference Citation Analysis]
2 Lu J, Fei F, Wu C, Mei J, Xu J, Lu P. ZEB1: Catalyst of immune escape during tumor metastasis. Biomedicine & Pharmacotherapy 2022;153:113490. [DOI: 10.1016/j.biopha.2022.113490] [Reference Citation Analysis]
3 Toraih EA, Fawzy MS, Ning B, Zerfaoui M, Errami Y, Ruiz EM, Hussein MH, Haidari M, Bratton M, Tortelote GG, Hilliard S, Nilubol N, Russell JO, Shama MA, El-dahr SS, Moroz K, Hu T, Kandil E. A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence. Cancers 2022;14:4128. [DOI: 10.3390/cancers14174128] [Reference Citation Analysis]
4 Fratini L, Dalmolin MGS, Sinigaglia M, da Silveira Perla A, de Farias CB, Brunetto AL, Brunetto AT, da Cunha Jaeger M, Roesler R. ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma. Neuromolecular Med 2022. [PMID: 35716340 DOI: 10.1007/s12017-022-08716-z] [Reference Citation Analysis]
5 Xu H, Ma Z, Mo X, Chen X, Xu F, Wu F, Chen H, Zhou G, Xia H, Zhang C. Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma. J Cancer 2022;13:2226-37. [PMID: 35517402 DOI: 10.7150/jca.66020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peng Z, Ouyang X, Wang Y, Fan Q. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis. BMC Mol Cell Biol 2022;23:21. [PMID: 35468721 DOI: 10.1186/s12860-022-00420-x] [Reference Citation Analysis]
7 Li X, Han M, Zhang H, Liu F, Pan Y, Zhu J, Liao Z, Chen X, Zhang B. Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma. Biomark Res 2022;10:2. [PMID: 35000617 DOI: 10.1186/s40364-021-00345-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang H, Jiang Z, Shen C, Zou H, Zhang Z, Wang K, Bai R, Kang Y, Ye XY, Xie T. 5-Hydroxymethylfurfural Alleviates Inflammatory Lung Injury by Inhibiting Endoplasmic Reticulum Stress and NLRP3 Inflammasome Activation. Front Cell Dev Biol 2021;9:782427. [PMID: 34966742 DOI: 10.3389/fcell.2021.782427] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Hu S, Yao Y, Wei ZY, Wang SX, Wu YC, Hu Y, Yang CC, Min JL, Li LY, Zhou H, Yang JF, Li J, Xu T. Deletion of p38γ attenuates ethanol consumption- and acetaminophen-induced liver injury in mice through promoting Dlg1. Acta Pharmacol Sin 2021. [PMID: 34789918 DOI: 10.1038/s41401-021-00795-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Samaržija I. Wnt Signaling Pathway Is among the Drivers of Liver Metastasis. Livers 2021;1:180-200. [DOI: 10.3390/livers1040015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jin X, Yin J, Zhu H, Li W, Yu K, Liu M, Zhang X, Lu M, Wan Z, Huang X. SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma. Front Pharmacol 2021;12:701454. [PMID: 34456727 DOI: 10.3389/fphar.2021.701454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]